PMID: 15841457

Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D, Kubitz R
Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Hepatology. 2005 May;41(5):1160-72., [PubMed]
Sentences
No. Mutations Sentence Comment
38 ABCB4 p.Thr175Ala
X
ABCB4 p.Thr175Ala 15841457:38:513
status: NEW
view ABCB4 p.Thr175Ala details
ABCB4 p.Ala953Asp
X
ABCB4 p.Ala953Asp 15841457:38:724
status: NEW
view ABCB4 p.Ala953Asp details
ABCC3 p.Ser346Ile
X
ABCC3 p.Ser346Ile 15841457:38:587
status: NEW
view ABCC3 p.Ser346Ile details
Clinical and Laboratory Parameters of PFIC Patients Patients Clinical Parameters Laboratory Parameters Diagnosis Onset of Symptoms Age at LTx BS (<8 ␮M) ␥GT (<25 U/l) Bilirubin (<1 mg/dL) MDR3-Mutation MDR3- IF BSEP- IF PFIC Type C1 F.A. 4 m 3 y 5 m 47 7 1.3 None detected ϩ - 2 C2 A.A. 3 m 2 y 5 m 144 19 22.6 None detected ϩ - 2 C3 S.H. 3 m 3 y 3 m 616 77 22.7 None detected ϩ - 2 C4 M.D. 6 m 10 y 7 m 160 7 5.4 None detected ϩ - 2 C5 T.A. 6 m 4 y 2 m 414 11 5.4 555 A 3 G/T175A Heterozygous ϩ - 2 C6 M.D. 4 m 7 y 9 m 163 26 11.2 1069 G 3 T/S346I ϩ ϩ 3 C7 S.F. birth 8 y 7 m 299 250 1.9 1069 G 3 T/8346I* ϩ ϩ 3 C8 K.Y. 6 m 3 y 10 m 85 277 0.5 2890 C 3 A/A953D ϩ ϩ 3 C9 K.B. 4 m 3 y 8 m 360 165 1.1 426-432 del† - ϩ 3 C10 B.D. 7 y 11 y 4 m 199 24 20.7 None detected - ϩ 3 NOTE. Login to comment
109 ABCB4 p.Ala953Asp
X
ABCB4 p.Ala953Asp 15841457:109:118
status: NEW
view ABCB4 p.Ala953Asp details
ABCB4 p.Ser346Ile
X
ABCB4 p.Ser346Ile 15841457:109:108
status: NEW
view ABCB4 p.Ser346Ile details
Two different mutations were found in the three patients with detectable canalicular MDR3 immunoreactivity (S346I and A953D). Login to comment
166 ABCB11 p.Asp482Gly
X
ABCB11 p.Asp482Gly 15841457:166:286
status: NEW
view ABCB11 p.Asp482Gly details
Defective BSEP targeting as an important mechanism underlying PFIC-2 was reported recently: 5 of 7 mutations prevented rat Bsep from trafficking to the apical membrane.37 Similarly, increased intracellular degradation and reduced canalicular targeting of mouse Bsep carrying the common D482G mutation was demonstrated recently.38 MDR3 immunofluorescence is of limited value in the diagnosis of PFIC-3, as shown by the association of disease-causing MDR3 mutations and normal canalicular MDR3 localization. Login to comment
167 ABCB4 p.Ser346Ile
X
ABCB4 p.Ser346Ile 15841457:167:13
status: NEW
view ABCB4 p.Ser346Ile details
The mutation S346I was detected in 2 children (C6 and C7). Login to comment
168 ABCB4 p.Ala953Asp
X
ABCB4 p.Ala953Asp 15841457:168:128
status: NEW
view ABCB4 p.Ala953Asp details
Normal canalicular MDR3 localization associated with this mutation was already reported for child C7.39 A second MDR3 mutation (A953D, C8) identified in this study has not been described so far. Login to comment
169 ABCB4 p.Ser346Ile
X
ABCB4 p.Ser346Ile 15841457:169:11
status: NEW
view ABCB4 p.Ser346Ile details
Similar to S346I, a canalicular staining pattern of MDR3 was observed in this patient. Login to comment
170 ABCB4 p.Val425Met
X
ABCB4 p.Val425Met 15841457:170:115
status: NEW
view ABCB4 p.Val425Met details
ABCB4 p.Thr424Ala
X
ABCB4 p.Thr424Ala 15841457:170:105
status: NEW
view ABCB4 p.Thr424Ala details
Additional PFIC-3 causing MDR3 mutations, which do not prevent MDR3 targeting to the canaliculi, include T424A and V425M.22,39 Preserved expression and targeting suggest that these MDR3 mutations cause decreased transporter activity. Login to comment
185 ABCB4 p.Thr175Ala
X
ABCB4 p.Thr175Ala 15841457:185:61
status: NEW
view ABCB4 p.Thr175Ala details
(PFIC-2 patient C5) results in an amino acid change in codon 175 from threonine to alanine. Login to comment